Randomized clinical trial: effect of the 5-HT(4) receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment

BACKGROUND: Approximately, 20–30% of patients with gastro-esophageal reflux disease (GERD) experience persistent symptoms despite treatment with proton pump inhibitors (PPIs). These patients may have underlying dysmotility; therefore, targeting gastric motor dysfunction in addition to acid inhibitio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tack, J, Zerbib, F, Blondeau, K, des Varannes, S B, Piessevaux, H, Borovicka, J, Mion, F, Fox, M, Bredenoord, A J, Louis, H, Dedrie, S, Hoppenbrouwers, M, Meulemans, A, Rykx, A, Thielemans, L, Ruth, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681320/
https://www.ncbi.nlm.nih.gov/pubmed/25530111
http://dx.doi.org/10.1111/nmo.12484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681320/
https://www.ncbi.nlm.nih.gov/pubmed/25530111
http://dx.doi.org/10.1111/nmo.12484

Ejemplares similares